USA Gastrointestinal OTC Drugs Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Gastrointestinal OTC Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Gastrointestinal OTC Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Gastrointestinal OTC Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Abbott

    • Perrigo

    • Tongrentang (TRT)

    • JZJT

    • China Resources Sanjiu Medical & Pharmaceutical

    • Xiuzheng Pharmaceutical Group

    • GlaxoSmithKline

    • Harbin Pharmaceutical Group

    • Boehringer Ingelheim

    • Pfizer

    • Purdue Pharma

    • Johnson & Johnson

    • CB Fleet

    • Bayer

    • Teva Pharmaceutical

    • Sanofi

    By Type:

    • Capsule

    • Tablet

    • Others

    By End-User:

    • Hospital Pharmacy

    • Retail Pharmacy

    • Online Pharmacy

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Gastrointestinal OTC Drugs Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Gastrointestinal OTC Drugs Market Size and Growth Rate of Capsule from 2016 to 2027

      • 1.3.2 USA Gastrointestinal OTC Drugs Market Size and Growth Rate of Tablet from 2016 to 2027

      • 1.3.3 USA Gastrointestinal OTC Drugs Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Gastrointestinal OTC Drugs Market Size and Growth Rate of Hospital Pharmacy from 2016 to 2027

      • 1.4.2 USA Gastrointestinal OTC Drugs Market Size and Growth Rate of Retail Pharmacy from 2016 to 2027

      • 1.4.3 USA Gastrointestinal OTC Drugs Market Size and Growth Rate of Online Pharmacy from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Gastrointestinal OTC Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Gastrointestinal OTC Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Gastrointestinal OTC Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Gastrointestinal OTC Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Gastrointestinal OTC Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Gastrointestinal OTC Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Capsule

      • 3.4.2 Market Size and Growth Rate of Tablet

      • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of Gastrointestinal OTC Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Gastrointestinal OTC Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Gastrointestinal OTC Drugs in Hospital Pharmacy

      • 4.4.2 Market Size and Growth Rate of Gastrointestinal OTC Drugs in Retail Pharmacy

      • 4.4.3 Market Size and Growth Rate of Gastrointestinal OTC Drugs in Online Pharmacy

    5 Market Analysis by Regions

    • 5.1 USA Gastrointestinal OTC Drugs Production Analysis by Regions

    • 5.2 USA Gastrointestinal OTC Drugs Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Gastrointestinal OTC Drugs Landscape Analysis

    • 6.1 West USA Gastrointestinal OTC Drugs Landscape Analysis by Major Types

    • 6.2 West USA Gastrointestinal OTC Drugs Landscape Analysis by Major End-Users

    7 South USA Gastrointestinal OTC Drugs Landscape Analysis

    • 7.1 South USA Gastrointestinal OTC Drugs Landscape Analysis by Major Types

    • 7.2 South USA Gastrointestinal OTC Drugs Landscape Analysis by Major End-Users

    8 Middle West USA Gastrointestinal OTC Drugs Landscape Analysis

    • 8.1 Middle West USA Gastrointestinal OTC Drugs Landscape Analysis by Major Types

    • 8.2 Middle West USA Gastrointestinal OTC Drugs Landscape Analysis by Major End-Users

    9 Northeast USA Gastrointestinal OTC Drugs Landscape Analysis

    • 9.1 Northeast USA Gastrointestinal OTC Drugs Landscape Analysis by Major Types

    • 9.2 Northeast USA Gastrointestinal OTC Drugs Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Abbott

        • 10.1.1 Abbott Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Perrigo

        • 10.2.1 Perrigo Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Tongrentang (TRT)

        • 10.3.1 Tongrentang (TRT) Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 JZJT

        • 10.4.1 JZJT Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 China Resources Sanjiu Medical & Pharmaceutical

        • 10.5.1 China Resources Sanjiu Medical & Pharmaceutical Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Xiuzheng Pharmaceutical Group

        • 10.6.1 Xiuzheng Pharmaceutical Group Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 GlaxoSmithKline

        • 10.7.1 GlaxoSmithKline Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Harbin Pharmaceutical Group

        • 10.8.1 Harbin Pharmaceutical Group Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Boehringer Ingelheim

        • 10.9.1 Boehringer Ingelheim Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Pfizer

        • 10.10.1 Pfizer Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Purdue Pharma

        • 10.11.1 Purdue Pharma Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Johnson & Johnson

        • 10.12.1 Johnson & Johnson Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 CB Fleet

        • 10.13.1 CB Fleet Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 Bayer

        • 10.14.1 Bayer Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

      • 10.15 Teva Pharmaceutical

        • 10.15.1 Teva Pharmaceutical Company Profile and Recent Development

        • 10.15.2 Market Performance

        • 10.15.3 Product and Service Introduction

      • 10.16 Sanofi

        • 10.16.1 Sanofi Company Profile and Recent Development

        • 10.16.2 Market Performance

        • 10.16.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Gastrointestinal OTC Drugs Market Size and Growth Rate of Capsule from 2016 to 2027

    • Figure USA Gastrointestinal OTC Drugs Market Size and Growth Rate of Tablet from 2016 to 2027

    • Figure USA Gastrointestinal OTC Drugs Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Gastrointestinal OTC Drugs Market Size and Growth Rate of Hospital Pharmacy from 2016 to 2027

    • Figure USA Gastrointestinal OTC Drugs Market Size and Growth Rate of Retail Pharmacy from 2016 to 2027

    • Figure USA Gastrointestinal OTC Drugs Market Size and Growth Rate of Online Pharmacy from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Gastrointestinal OTC Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Gastrointestinal OTC Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Gastrointestinal OTC Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Gastrointestinal OTC Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Gastrointestinal OTC Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Gastrointestinal OTC Drugs

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Gastrointestinal OTC Drugs by Different Types from 2016 to 2027

    • Table Consumption Share of Gastrointestinal OTC Drugs by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Capsule

    • Figure Market Size and Growth Rate of Tablet

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Gastrointestinal OTC Drugs by Different End-Users from 2016 to 2027

    • Table Consumption Share of Gastrointestinal OTC Drugs by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital Pharmacy

    • Figure Market Size and Growth Rate of Retail Pharmacy

    • Figure Market Size and Growth Rate of Online Pharmacy

    • Table USA Gastrointestinal OTC Drugs Production by Regions

    • Table USA Gastrointestinal OTC Drugs Production Share by Regions

    • Figure USA Gastrointestinal OTC Drugs Production Share by Regions in 2016

    • Figure USA Gastrointestinal OTC Drugs Production Share by Regions in 2021

    • Figure USA Gastrointestinal OTC Drugs Production Share by Regions in 2027

    • Table USA Gastrointestinal OTC Drugs Consumption by Regions

    • Table USA Gastrointestinal OTC Drugs Consumption Share by Regions

    • Figure USA Gastrointestinal OTC Drugs Consumption Share by Regions in 2016

    • Figure USA Gastrointestinal OTC Drugs Consumption Share by Regions in 2021

    • Figure USA Gastrointestinal OTC Drugs Consumption Share by Regions in 2027

    • Table West USA Gastrointestinal OTC Drugs Consumption by Types from 2016 to 2027

    • Table West USA Gastrointestinal OTC Drugs Consumption Share by Types from 2016 to 2027

    • Figure West USA Gastrointestinal OTC Drugs Consumption Share by Types in 2016

    • Figure West USA Gastrointestinal OTC Drugs Consumption Share by Types in 2021

    • Figure West USA Gastrointestinal OTC Drugs Consumption Share by Types in 2027

    • Table West USA Gastrointestinal OTC Drugs Consumption by End-Users from 2016 to 2027

    • Table West USA Gastrointestinal OTC Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Gastrointestinal OTC Drugs Consumption Share by End-Users in 2016

    • Figure West USA Gastrointestinal OTC Drugs Consumption Share by End-Users in 2021

    • Figure West USA Gastrointestinal OTC Drugs Consumption Share by End-Users in 2027

    • Table South USA Gastrointestinal OTC Drugs Consumption by Types from 2016 to 2027

    • Table South USA Gastrointestinal OTC Drugs Consumption Share by Types from 2016 to 2027

    • Figure South USA Gastrointestinal OTC Drugs Consumption Share by Types in 2016

    • Figure South USA Gastrointestinal OTC Drugs Consumption Share by Types in 2021

    • Figure South USA Gastrointestinal OTC Drugs Consumption Share by Types in 2027

    • Table South USA Gastrointestinal OTC Drugs Consumption by End-Users from 2016 to 2027

    • Table South USA Gastrointestinal OTC Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Gastrointestinal OTC Drugs Consumption Share by End-Users in 2016

    • Figure South USA Gastrointestinal OTC Drugs Consumption Share by End-Users in 2021

    • Figure South USA Gastrointestinal OTC Drugs Consumption Share by End-Users in 2027

    • Table Middle West USA Gastrointestinal OTC Drugs Consumption by Types from 2016 to 2027

    • Table Middle West USA Gastrointestinal OTC Drugs Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Gastrointestinal OTC Drugs Consumption Share by Types in 2016

    • Figure Middle West USA Gastrointestinal OTC Drugs Consumption Share by Types in 2021

    • Figure Middle West USA Gastrointestinal OTC Drugs Consumption Share by Types in 2027

    • Table Middle West USA Gastrointestinal OTC Drugs Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Gastrointestinal OTC Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Gastrointestinal OTC Drugs Consumption Share by End-Users in 2016

    • Figure Middle West USA Gastrointestinal OTC Drugs Consumption Share by End-Users in 2021

    • Figure Middle West USA Gastrointestinal OTC Drugs Consumption Share by End-Users in 2027

    • Table Northeast USA Gastrointestinal OTC Drugs Consumption by Types from 2016 to 2027

    • Table Northeast USA Gastrointestinal OTC Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Gastrointestinal OTC Drugs Consumption Share by Types in 2016

    • Figure Northeast USA Gastrointestinal OTC Drugs Consumption Share by Types in 2021

    • Figure Northeast USA Gastrointestinal OTC Drugs Consumption Share by Types in 2027

    • Table Northeast USA Gastrointestinal OTC Drugs Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Gastrointestinal OTC Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Gastrointestinal OTC Drugs Consumption Share by End-Users in 2016

    • Figure Northeast USA Gastrointestinal OTC Drugs Consumption Share by End-Users in 2021

    • Figure Northeast USA Gastrointestinal OTC Drugs Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott

    • Table Company Profile and Development Status of Perrigo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Perrigo

    • Figure Sales and Growth Rate Analysis of Perrigo

    • Figure Revenue and Market Share Analysis of Perrigo

    • Table Product and Service Introduction of Perrigo

    • Table Company Profile and Development Status of Tongrentang (TRT)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tongrentang (TRT)

    • Figure Sales and Growth Rate Analysis of Tongrentang (TRT)

    • Figure Revenue and Market Share Analysis of Tongrentang (TRT)

    • Table Product and Service Introduction of Tongrentang (TRT)

    • Table Company Profile and Development Status of JZJT

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of JZJT

    • Figure Sales and Growth Rate Analysis of JZJT

    • Figure Revenue and Market Share Analysis of JZJT

    • Table Product and Service Introduction of JZJT

    • Table Company Profile and Development Status of China Resources Sanjiu Medical & Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Resources Sanjiu Medical & Pharmaceutical

    • Figure Sales and Growth Rate Analysis of China Resources Sanjiu Medical & Pharmaceutical

    • Figure Revenue and Market Share Analysis of China Resources Sanjiu Medical & Pharmaceutical

    • Table Product and Service Introduction of China Resources Sanjiu Medical & Pharmaceutical

    • Table Company Profile and Development Status of Xiuzheng Pharmaceutical Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Xiuzheng Pharmaceutical Group

    • Figure Sales and Growth Rate Analysis of Xiuzheng Pharmaceutical Group

    • Figure Revenue and Market Share Analysis of Xiuzheng Pharmaceutical Group

    • Table Product and Service Introduction of Xiuzheng Pharmaceutical Group

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Harbin Pharmaceutical Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Harbin Pharmaceutical Group

    • Figure Sales and Growth Rate Analysis of Harbin Pharmaceutical Group

    • Figure Revenue and Market Share Analysis of Harbin Pharmaceutical Group

    • Table Product and Service Introduction of Harbin Pharmaceutical Group

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Purdue Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma

    • Figure Sales and Growth Rate Analysis of Purdue Pharma

    • Figure Revenue and Market Share Analysis of Purdue Pharma

    • Table Product and Service Introduction of Purdue Pharma

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of CB Fleet

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CB Fleet

    • Figure Sales and Growth Rate Analysis of CB Fleet

    • Figure Revenue and Market Share Analysis of CB Fleet

    • Table Product and Service Introduction of CB Fleet

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Teva Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical

    • Table Product and Service Introduction of Teva Pharmaceutical

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.